SEATTLE--(EON: Enhanced Online News)--Visualant, Inc. (OTCQB: VSUL), a leading provider of disruptive light-based technologies, announced today that they have retained Genesis Select as strategic consultants to oversee capital markets activity, including developing greater Wall Street awareness.
“We look forward to working with Ron and his team at Visualant”
Genesis Select will support Visualant’s efforts to cultivate long-term relationships with the investment community. Specifically, Genesis Select will make introductions to leading industry analysts focused on identification, validation and image analysis.
"Genesis Select is known for raising awareness of emerging small and micro-cap companies. While the Company focuses its efforts on growing our business and penetrating development channels, we look to Genesis to convey our story to Wall Street," said Ron Erickson, chief executive officer of Visualant.
"We look forward to working with Ron and his team at Visualant," said Budd Zuckerman, President of Genesis Select. "We believe that Visualant’s patented Spectral Pattern Matching™ technology, used in their hand-held chromatic identifier will have a revolutionary impact in multiple markets. Because everything in the world has a unique machine readable chromatic identifier, this technology raises the bar in authentication, identification, verification and quality control at an affordable price point in contrast to Spectrophotometry,” added Zuckerman.
About Visualant, Inc.
Visualant™ is a public company whose shares trade under the stock symbol “VSUL.” The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests.